To be added to MEHP's events listserv, please contact Mary.Pham@pennmedicine.upenn.edu
See the full Research Ethics and Policy Series schedule and the Penn Bioethics Seminar Series schedule.
Events
In-person: Jordan 506 EW Seminar Rm Jordan Medical Education Center
Research Ethics and Policy Series: Rita F. Redberg, MD, MS
Learn More
2022-12-05 12:00:00
2022-12-05 13:00:00
America/New_York
Research Ethics and Policy Series: Rita F. Redberg, MD, MS
The Division of Medical Ethics and Penn Health-Tech present:
Ethics and Medical Device Regulation: Balancing Safety and Innovation
Rita F. Redberg, MD, MSc
General Cardiologist and Professor of Medicine,
University of California San Francisco
In-person! Livestreaming also available.
Boxed lunches will be provided for in-person attendees.
Abstract: The standard for approving medical devices for clinical use is generally lower than the standard for drug approvals, and often does not require clinical data. There are an increasing number of programs to fast-track or accelerate devices reaching market, in the name of “innovation”. However, these expedited approvals mean there is more uncertainty about safety and effectiveness of devices for clinical use at time of approval. It also means there is more reliance on post marketing data. It is unclear how much patients (or doctors) are aware of these considerations, during the consent process or anytime in clinical care. This talk will summarize the present landscape and suggest some improvements to assure patient safety.
Rita F. Redberg, MD, MSc, is a cardiologist and Professor of Medicine at the University of California, San Francisco since 1990 and Core Faculty, Philip R Lee Institute for Health Policy Studies. After growing up in Brooklyn, she graduated from Cornell University and the University of Pennsylvania Medical School. She got a Master’s degree at the London School of Economics. Dr. Redberg is the Chief Editor of JAMA Internal Medicine since 2009 and has spearheaded the journal’s new focus on health care reform and “less is more”. Her research interests are in the area of health policy and technology assessment, and how to promote high value care, focusing on high risk medical devices as well as the need for inclusion of women in clinical trials of such devices.
Dr. Redberg served on the Medicare Payment Advisory Commission, which advises Congress on Medicare payment issues. She also served and chaired the Medicare Evidence, Development and Coverage Advisory Committee.
She has given Congressional testimony multiple times in hearings related to the issue of balancing safety and innovation in medical device approvals. Dr. Redberg worked in the office of Senator Hatch and with the Senate Judiciary Committee on FDA-related matters during her tenure as a Robert Wood Johnson Health Policy Fellow, 2003-2006. Dr. Redberg is a member of the National Academy of Medicine.
For more information, contact Mary Pham, Mary.Pham@pennmedicine.upenn.edu.
In-person: Jordan 506 EW Seminar Rm Jordan Medical Education Center
Penn Medical Ethics
In-person: 1402 Blockley Hall, 423 Guardian Drive, 14th floor
Penn Bioethics Seminar Series: Marina Di Bartolo, MD and Niharika Sathe, MD, MHS
Learn More
2022-12-06 12:00:00
2022-12-06 13:00:00
America/New_York
Penn Bioethics Seminar Series: Marina Di Bartolo, MD and Niharika Sathe, MD, MHS
Ethics in Ambulatory Medicine
Marina Di Bartolo, MD, Assistant Professor of Medicine, Cooper Medical School of Rowan University
Niharika Sathe, MD, MHS, Assistant Professor of Medicine at Cooper Medical School of Rowan University
In-person! Livestreaming also available.
Boxed lunches will be provided for in-person attendees.
Abstract: Much attention has gone into the study of ethical issues that arise in clinical encounters in the inpatient setting - for example, issues that arise in end of life, with allocation of scarce ICU resources. Issues that arise in outpatient medicine, such as firing of disruptive patients, prescription of controlled substances or how physicians interact with the pharmaceutical industry, are often less studied and discussed even though the majority of medicine occurs in this setting. We seek in this hour to shed light on these issues and encourage discussion on how to address these issues.
For more information, contact Mary Pham, Mary.Pham@pennmedicine.upenn.edu.
In-person: 1402 Blockley Hall, 423 Guardian Drive, 14th floor
Penn Medical Ethics
HYBRID SEMINAR
Claudio Lucarelli, PhD │ CHIBE X PSOM Hybrid Research Seminar
Learn More
2022-12-08 12:00:00
2022-12-08 13:00:00
America/New_York
Claudio Lucarelli, PhD │ CHIBE X PSOM Hybrid Research Seminar
Claudio Lucarelli, PhD │ CHIBE X PSOM Hybrid Research Seminar
DECEMBER 8 @ 12:00 PM - 1:00 PM
DEANS’ DISTINGUISHED VISITING PROFESSORSHIP
Claudio Lucarelli, PhD | Associate Professor of Health Care Management, The Wharton School
12:00-1:00 PM EST | 12/8/2022 | HYBRID SEMINAR
In Person: 1104 Blockley Hall, 423 Guardian Drive | Virtual: Attendees may attend via Zoom (https://upenn.zoom.us/j/95353951407)
“The Relative Weights of Income & Substitution Effects in Insurance”.
HYBRID SEMINAR
Penn Medical Ethics
JMB Class of '62
The Ethics of Transplanting Organs from Donors with HIV or Hepatitis C Infection
Learn More
2022-12-08 16:30:00
2022-12-08 17:30:00
America/New_York
The Ethics of Transplanting Organs from Donors with HIV or Hepatitis C Infection
Please join us for the Program in Surgical Ethics and Health Policy’s inaugural lecture: The Ethics of Transplanting Organs from Donors with HIV or Hepatitis C Infection featuring guest speakers Dr. Jeremy Sugarman and Dr. Peter Reese on Thursday, December 8th at 4:30 pm in JMB Class of ’62 Auditorium. Event is free and open to all. Click here to learn more and to RSVP.
JMB Class of '62
Penn Medical Ethics
Virtual, via Zoom
Penn Bioethics Seminar Series: Jasmine E. Harris, JD
Learn More
2022-12-13 12:00:00
2022-12-13 13:00:00
America/New_York
Penn Bioethics Seminar Series: Jasmine E. Harris, JD
Locating Disability Within a Health Justice Framework
Jasmine E. Harris, JD
Professor of Law, University of Pennsylvania Carey Law School
Via Zoom
Boxed lunches will be provided for in-person attendees.
Paper presentation (Journal of Law, Medicine, & Ethics)
Except from intro:
According to William Kissick, three core principles—access, cost, and quality—tradeoff to shape the contours of healthcare law and policy. Concerns with these tradeoffs have occupied health law and policy for decades. Health justice scholars have moved the needle beyond the “iron triangle” to recognize that this understanding of health law “lacks the ambition and scope” to respond to difficult cross-cutting structural issues. Part of their efforts to expand the relevant lens of research and scholarly inquiry has focused on the causes of inequitable healthcare outcomes by attending to the social determinants of health. The rhetorical, analytical, and practical positioning of disability within a health justice framework affects problem identification and remedial efforts, but also sends a clear message to disabled people about disability as identity and their quality of life.
This article contributes to ongoing conversations about the relationship between disability and health justice, identifies points of overlap, tension, and departure through a case study, and calls for greater integration of disability into health justice scholarship and practice. For purposes of this discussion, disability refers to a physical or mental impairment that limits an individual’s functional capacity while also recognizing the “disabling” nature of the impairment can be rooted in and exacerbated by structural and institutional choices that fail to account for nonnormative bodies and minds. The relationship of disability to health and health law is complex and the subject of scholarly debate due to narrow conceptions of disability as an individual health outcome rather than a socio-political identity. Is disability a medical impairment, a diagnosis, a “bad difference” or a “mere difference” on a broad spectrum of human capability? These debates are outside of the scope of this Article; however, the very existence of these debates affects whether and where disability appears in health justice conversations.
Disability is more than just a downstream data point that evinces inequities along other axes of marginalization such as a race, gender, class, sexuality, or immigration status. Disability should be a meaningful part of upstream legal and policy interventions to make good on the theory and practice of health justice. Reduction of disability to health outcomes reinforces the medical model of disability—a limited view of disability as individual, physiological deficit—that the disability rights movement has worked to change. Disabled people encounter barriers to healthcare access, and research suggests that when they access healthcare institutions, they may experience poorer outcomes. But access barriers and poor outcomes are only part of the story.
Attention to the complexity of disability as socio-political identity and as health status positions disability as a critical analytic point of entry into a discussion of social inequities that, at times, uses disability as a label or tool of structural subordination and social sorting. Asking the disability question, as Professor Mari Matsuda has explained, can identify cross-movement points of oppression or subordination as well as opportunities for liberation. Thus, examining where disability is situated in the health justice agenda opens a discussion about disability as identity or disability as evidence of health injustice. Moreover, it continues the work of scholars concerned with how to reconcile antidiscrimination and health law.
For more information, contact Mary Pham, Mary.Pham@pennmedicine.upenn.edu.
Virtual, via Zoom
Penn Medical Ethics